Multi-site Left Ventricular (MSLV) Pacing With Quartet 1458Q Lead (MSLV)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years and older (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Patients with standard CRT-D indications
Patients who have a recognised indication to receive a CRT-D device or an upgrade from a pacemaker or ICD to a CRT-D system.
Patients have signed an informed consent form indicating their willingness to participate to this study.
Patients who are unable to comply with the follow-up schedule based on their geographic location or for any reason.
Patients with second or third degree AV Block
Patients with intrinsic atrial rhythm < 40 bpm
Patients with a previously implanted left ventricular pacing lead.
Patients who are pregnant.
Patients currently participating in a clinical investigation that includes an active treatment arm.
Patients under 18 years of age.
Patients with a life expectancy of less then 6 months.